GYRE (GYRE) COO sells 22,220 shares after stock option exercises
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GYRE THERAPEUTICS, INC. Chief Operating Officer Ye Weiguo reported option exercises and related share sales. He exercised stock options covering 22,220 shares of common stock at an exercise price of $0.75 per share and sold the same number of shares in open-market transactions.
The common stock sales on May 20 and May 21, 2026 were executed at a weighted average price of $6.15 per share, with actual sale prices ranging from about $6.05 to $6.29 according to the footnotes. After these transactions, Ye directly owns 700,000 shares of GYRE common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 22,220 shares ($136,653)
Net Sell
6 txns
Insider
Ye Weiguo
Role
Chief Operating Officer
Sold
22,220 shs ($137K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 12,820 | $0.00 | -- |
| Exercise | Common Stock | 12,820 | $0.75 | $10K |
| Sale | Common Stock | 12,820 | $6.15 | $79K |
| Exercise | Stock Option (Right to Buy) | 9,400 | $0.00 | -- |
| Exercise | Common Stock | 9,400 | $0.75 | $7K |
| Sale | Common Stock | 9,400 | $6.15 | $58K |
Holdings After Transaction:
Stock Option (Right to Buy) — 904,895 shares (Direct, null);
Common Stock — 712,820 shares (Direct, null)
Footnotes (1)
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.0908 to $6.2935. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.05 to $6.22. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. These options are vested in full.
Key Figures
Shares sold: 22,220 shares
Weighted average sale price: $6.15/share
Options exercised: 22,220 shares
+3 more
6 metrics
Shares sold
22,220 shares
Total GYRE common shares sold in open-market transactions
Weighted average sale price
$6.15/share
Average price for reported GYRE common stock sales
Options exercised
22,220 shares
Common shares acquired through stock option exercises
Exercise price
$0.75/share
Conversion price of stock options into GYRE common stock
Common shares held
700,000 shares
Direct GYRE common stock holdings after transactions
Option expiration date
October 31, 2030
Expiration of exercised stock options
Key Terms
open-market sale, Stock Option (Right to Buy), weighted average sale price per share, derivative security
4 terms
open-market sale financial
"transaction_action: "open-market sale" for common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" in derivative entries"
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What did GYRE COO Ye Weiguo report in this Form 4 filing for GYRE?
Ye Weiguo reported exercising stock options and selling GYRE common shares. He exercised options for 22,220 shares at $0.75 each, then sold 22,220 shares in open-market transactions at a weighted average price of $6.15 per share over two days.
What stock options did the GYRE COO exercise according to the Form 4?
He exercised stock options labeled as "Stock Option (Right to Buy)" for 22,220 underlying common shares. These options carried a conversion or exercise price of $0.75 per share and have an expiration date of October 31, 2030, and are described as vested in full.